The Oregon Clinical & Translational Research Institute (OCTRI) is pleased to announce the funding of three research awards through its Biomedical Innovation Program. The BIP aims to cultivate, select and provide strong program management for promising translational projects that develop new biomedical devices, diagnostics, and software. The primary objective of the BIP is to facilitate development of innovative technologies from academia to the marketplace, and thus to make a meaningful impact on human health.
The Biomedical Innovation Program is a collaboration between OCTRI and OHSU Technology Transfer and Business Development (TTBD). It is supported by major funding from OCTRI, and institutional support from OHSU, with additional support from Oregon Translational Research and Development Institute (OTRADI).
Congratulations to our 2016 Biomedical Innovation Pilot Award winners:
“The Biomedical Innovation Program meets a critical need at OHSU by funding promising early stage and potentially marketable technologies,” said OCTRI Director David Ellison, M.D. “This funding, along with project management and mentorship, helps move the needle substantially, to put these technologies in the best possible position for commercialization where they can ultimately improve patient outcomes. We are very excited to fund these new technologies for 2016, and look forward to working closely with the investigators.”
Detailed information on all three awards, including project abstracts is provided on the OCTRI website.
For more information on OCTRI’s resource services, please visit www.octri.org. OCTRI is supported by (UL1TR000128) from the National Center for Advancing Translational Science (NCATS) at the National Institutes of Health (NIH).